News Daily News Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks Michael O'Riordan August 01, 2025
News Daily News Weight-Loss Drug MariTide Gains Momentum in Phase II Trial Caitlin E. Cox June 25, 2025
News Daily News Majority of US Adults Have High Long-term Risk of CVD: NHANES Michael O'Riordan June 13, 2025
News Conference News ACC 2025 SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes Michael O'Riordan March 29, 2025
News Features Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts Michael O'Riordan October 21, 2024
News Daily News Medicaid Coverage Improves CV Risk in Some, Post Hoc Analysis Shows Todd Neale September 25, 2024
News Daily News Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients L.A. McKeown July 24, 2024
News Daily News Think You Need a Statin? AHA’s Risk Calculator May Disagree Michael O'Riordan June 28, 2024
News Daily News Universal Risk Tool Works Well in Both Primary and Secondary Prevention Michael O'Riordan February 01, 2024
News Conference News AHA 2023 DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI Shelley Wood November 11, 2023
News Daily News Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study L.A. McKeown October 10, 2023
News Daily News PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY Michael O'Riordan September 29, 2023
News Conference News ESC 2023 New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground Caitlin E. Cox August 30, 2023
News Daily News Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE Michael O'Riordan July 25, 2023